Skip to content

Clinical trials

Myocardial Infarction trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Country / region: South Korea Clear all

78 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20031
20042
20051
20063
20076
20082
20097
20102
20111
20136
20144
20153
20162
20172
20183
20193
20206
20216
20223
20233
20242
20252
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Recruiting13
Unknown status11
Terminated10
Not yet recruiting3
Active, not recruiting3
Temporarily not available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chonnam National University Hospital12
Seoul National University Hospital10
Yonsei University8
Samsung Medical Center4
AstraZeneca3
Boehringer Ingelheim3
Novartis Pharmaceuticals3
CHA University2
Janssen Research & Development, LLC2
Pfizer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction78
Acute Coronary Syndrome14
Coronary Artery Disease14
Cardiovascular Diseases11
Stroke11
Angina, Unstable7
Myocardial Ischemia7
ST Elevation Myocardial Infarction7
Non-ST Elevated Myocardial Infarction5
Heart Diseases4

Trials

Showing 1 to 25 of 78. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.